LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research free cash flow 1989–2027

Lam Research's free cash flow in Q1 FY2027, the three months to 27 September 2026, was 3.24B USD, up 103.3% on the same quarter a year before. Lam Research's free cash flow over the last twelve months was 6.54B USD, up 17.8% on the twelve months before. In fiscal year 2026 it was 4.89B USD, down 9.7% on the year before.

Last updated 8 Nov 2026 · Next report 27 Jan 2027

Free cash flow

Free cash flow · +15.3% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM27 Sept 20266.54B+17.79%25.02%7.58B-1.04B5.19
FY202628 Jun 20264.89B-9.66%21.05%5.86B-966.41M3.88
FY202529 Jun 20255.41B+27.22%29.37%6.17B-759.19M4.20
FY202430 Jun 20244.26B-9.02%28.55%4.65B-396.67M3.22
FY202325 Jun 20234.68B+83.16%26.84%5.18B-501.57M3.44
FY202226 Jun 20222.55B-21.16%14.82%3.10B-546.03M1.82
FY202127 Jun 20213.24B+68.42%22.15%3.59B-349.10M2.23
FY202028 Jun 20201.92B-33.05%19.15%2.13B-203.24M1.29
FY201930 Jun 20192.87B+20.58%29.76%3.18B-303.49M1.80
FY201830 Jun 20182.38B+27.27%21.51%2.66B-273.47M1.32
FY201730 Jun 20171.87B+59.31%23.36%2.03B-157.42M1.02
FY201630 Jun 20161.17B+100.08%19.96%1.35B-175.33M0.67
FY201530 Jun 2015587.24M+2.75%11.17%785.50M-198.27M0.33
FY201430 Jun 2014571.55M+2.22%12.41%717.05M-145.50M0.33
FY201330 Jun 2013559.14M+42.73%15.54%719.93M-160.80M0.32
FY201230 Jun 2012391.76M-48.01%14.70%499.03M-107.27M0.31
FY201130 Jun 2011753.53M+139.12%23.27%881.03M-127.50M0.60
FY201030 Jun 2010315.12M—14.77%350.71M-35.59M0.25
FY200930 Jun 2009-122.41M-123.84%-10.97%-78.13M-44.28M-0.10
FY200830 Jun 2008513.52M-32.75%20.75%590.32M-76.80M0.41
FY200730 Jun 2007763.59M+139.67%29.75%823.56M-59.97M0.54
FY200630 Jun 2006318.61M-20.96%19.40%360.69M-42.08M0.22
FY200530 Jun 2005403.08M+202.79%26.83%425.93M-22.85M0.28
FY200430 Jun 2004133.12M+133.64%14.22%157.15M-24.03M0.09
FY200330 Jun 200356.98M+409.73%7.54%69.24M-12.26M0.05
FY200230 Jun 200211.18M-94.32%1.19%21.80M-10.62M0.01
FY200130 Jun 2001196.89M+183.34%12.96%261.29M-64.40M0.15
FY200030 Jun 200069.49M—5.65%119.85M-50.36M0.05
FY199930 Jun 1999-70.40M-6,882.08%-10.86%-37.22M-33.18M-0.06
FY199830 Jun 19981.04M-97.44%0.10%51.25M-50.21M0.00
FY199730 Jun 199740.62M—4.05%80.17M-39.55M0.04
FY199630 Jun 1996-39.98M—-3.05%26.61M-66.59M-0.04
FY199530 Jun 1995-44.31M—-5.55%19.10M-63.41M-0.05
FY199430 Jun 1994-12.70M—-2.62%6.30M-19.00M-0.01
FY199330 Jun 1993-23.80M—-9.14%-9.60M-14.20M-0.03
FY199230 Jun 1992-6.30M—-3.80%2.60M-8.90M-0.01
FY199130 Jun 1991-13.40M—-9.71%-400.00K-13.00M-0.02
FY199030 Jun 1990-5.90M—-4.30%4.00M-9.90M-0.01
FY198930 Jun 1989-10.10M—-8.02%-3.70M-6.40M-0.02

Figures in USD. Free cash flow is operating cash flow less capital expenditure. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Lam Research's free cash flow

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.